CURE vs. NVDG
CURE (Direxion Daily Healthcare Bull 3x Shares) and NVDG (Leverage Shares 2X Long NVDA Daily ETF) are both Leveraged Equities funds. CURE is passively managed, while NVDG is actively managed. Over the past year, CURE returned 67.78% vs 10.44% for NVDG. Their 0.00 correlation means their historical movements had little consistent relationship. CURE charges 0.94%/yr vs 0.75%/yr for NVDG.
Performance
CURE vs. NVDG - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, CURE achieves a 6.43% return, which is significantly higher than NVDG's 5.32% return.
CURE
- 1D
- -0.52%
- 1M
- -4.06%
- 6M
- 6.28%
- YTD
- 6.43%
- 1Y
- 67.78%
- 3Y*
- 7.93%
- 5Y*
- 0.06%
- 10Y*
- 13.34%
- ALL TIME*
- 24.18%
NVDG
- 1D
- 5.70%
- 1M
- 10.50%
- 6M
- 8.19%
- YTD
- 5.32%
- 1Y
- 10.44%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 22.15%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $8.76M | $9.12M | $9.34M | |
| $3.04M | $4.02M | $6.35M |
CURE vs. NVDG - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 6.43% | 22.55% | -6.58% |
NVDG Leverage Shares 2X Long NVDA Daily ETF | 5.32% | 32.45% | -0.52% |
Correlation
The correlation between CURE and NVDG is -0.11, meaning they have often moved in opposite directions in the past. This relationship can weaken or reverse as market conditions change.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | -0.11 |
Correlation (All Time) Calculated using the full available price history since Dec 13, 2024 | 0.00 |
The correlation between CURE and NVDG shifts across timeframes, from -0.11 (1 year) to 0.00 (all time), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
CURE vs. NVDG — Risk / Return Rank
CURE
NVDG
CURE vs. NVDG - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily Healthcare Bull 3x Shares (CURE) and Leverage Shares 2X Long NVDA Daily ETF (NVDG). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| CURE | NVDG | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +1.33 | ||
| Sortino ratioReturn per unit of downside risk | +1.54 | ||
| Omega ratioGain probability vs. loss probability | 1.25 | 1.08 | +0.16 |
| Calmar ratioReturn relative to maximum drawdown | 2.19 | 0.25 | +1.95 |
| Martin ratioReturn relative to average drawdown | 4.92 | 0.48 | +4.44 |
Loading charts...
Drawdowns
CURE vs. NVDG - Drawdown Comparison
The maximum CURE drawdown since its inception was -69.19%, roughly equal to the maximum NVDG drawdown of -66.19%. Use the drawdown chart below to compare losses from any high point for CURE and NVDG.
Loading charts...
Drawdown Indicators
| CURE | NVDG | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -69.19% | -66.19% | -3.00% |
Max Drawdown (1Y)Largest decline over 1 year | -31.10% | -42.72% | +11.62% |
Max Drawdown (3Y)Largest decline over 3 years | -51.93% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -52.23% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -69.19% | — | — |
Current DrawdownCurrent decline from peak | -15.52% | -27.68% | +12.16% |
Average DrawdownAverage peak-to-trough decline | -18.16% | -23.53% | +5.37% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 13.83% | 22.03% | -8.20% |
Volatility
CURE vs. NVDG - Volatility Comparison
The current volatility for Direxion Daily Healthcare Bull 3x Shares (CURE) is 15.88%, while Leverage Shares 2X Long NVDA Daily ETF (NVDG) has a volatility of 24.88%. This indicates that CURE experiences smaller price fluctuations and is considered to be less risky than NVDG based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| CURE | NVDG | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.88% | 24.88% | -9.00% |
Volatility (6M)Calculated over the trailing 6-month period | 35.22% | 56.20% | -20.98% |
Volatility (1Y)Calculated over the trailing 1-year period | 46.17% | 72.40% | -26.23% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 44.67% | 89.75% | -45.08% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 49.87% | 89.75% | -39.88% |
CURE vs. NVDG - Expense Ratio Comparison
CURE has a 0.94% expense ratio, which is higher than NVDG's 0.75% expense ratio.
Dividends
CURE vs. NVDG - Dividend Comparison
CURE's dividend yield for the trailing twelve months is around 1.07%, less than NVDG's 11.22% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
CURE Direxion Daily Healthcare Bull 3x Shares | 1.07% | 1.12% | 1.17% | 2.02% | 0.38% | 0.02% | 0.17% | 0.40% | 0.70% | 0.18% |
NVDG Leverage Shares 2X Long NVDA Daily ETF | 11.22% | 11.81% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
CURE and NVDG have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
NVDG has higher volatility (24.88%) compared to CURE (15.88%). In terms of maximum drawdown, CURE dropped -69.19% vs NVDG's -66.19%.
On 1-year performance, CURE leads with 67.78% vs 10.44% for NVDG. On fees, NVDG is cheaper at 0.75% per year. On volatility, CURE has been the lower-risk option at 15.88%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, CURE has performed better with a 67.78% return vs 10.44%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
NVDG is cheaper with a 0.75% expense ratio, compared with 0.94% for CURE.
NVDG has the higher dividend yield at 11.22%, compared with 1.07% for CURE.
They also come from different issuers: Direxion and Leverage Shares. Their fees differ too: 0.94% for CURE and 0.75% for NVDG.
CURE currently has the higher Sharpe Ratio (1.48 vs 0.15), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for CURE and NVDG
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer